|
May 2
|
1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar
|
|
May 1
|
Jim Cramer Says He Likes Bristol-Myers Squibb (BMY) More Than Merck Due to Schizophrenia Drug
|
|
May 1
|
Bristol-Myers Squibb's (NYSE:BMY) Strong Earnings Are Of Good Quality
|
|
Apr 30
|
Is Bristol-Myers Squibb Company (BMY) the Best Long-Term Dividend Stock to Buy According to Billionaires?
|
|
Apr 29
|
Here is What to Know Beyond Why Bristol Myers Squibb Company (BMY) is a Trending Stock
|
|
Apr 28
|
Jim Cramer is Recommending This Dividend Stock With 5% Yield for ‘Good Protection’
|
|
Apr 28
|
BMSCH announces Children’s Same Day Services centre in the US
|
|
Apr 28
|
BMY Falls 4% Post Q1 Earnings: Should You Buy, Sell or Hold the Stock?
|
|
Apr 19
|
Bristol Myers says FDA updates Camzyos label to simplify treatment
|
|
Apr 18
|
Bristol-Myers Squibb (NYSE:BMY) Gains FDA Approval To Simplify Camzyos Monitoring Process
|
|
Apr 18
|
Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
|
|
Apr 18
|
Stocks to watch next week: Tesla, Alphabet, Intel, Boeing and Unilever
|
|
Apr 18
|
U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications
|
|
Apr 17
|
Should You Buy, Hold, or Sell BMY Stock Ahead of Q1 Earnings?
|
|
Apr 17
|
Bristol Myers Squibb (BMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
|
Apr 16
|
Bristol Myers Squibb (BMY) Stock Moves -1.35%: What You Should Know
|
|
Apr 16
|
Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?
|
|
Apr 16
|
Biotech Stock Roundup: BMY Down on Study Failure, VERV Up on Study Data & More News
|
|
Apr 16
|
Gilead vs Bristol Myers: Which Biotech Bigwig is a Better Bet Now?
|
|
Apr 15
|
BMS’ Camzyos flops in Phase III non-obstructive hypertrophic cardiomyopathy trial
|